In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
Cigna Group plans to make changes to help lower out-of-pocket cost of prescription drugs, the company said on Wednesday, as ...
At today's confirmation hearing, Democratic senators were skeptical of the HHS Secretary nominee Robert F. Kennedy Jr.'s ...
Excerpts from recent editorials in the United States and abroad: ___ Jan. 26 The Washington Post on Trump's “energy emergency” Oil and gas production in the United States is hitting record highs, ...
The association says pharmacy benefit managers (PBM’s) are to blame ... calls them anti-competitive middlemen in the pharmacy supply chain that have been allowed to operate largely unregulated.
The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...
Payer-PBM Relationships For everything from GLP-1 ... Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges?
which play a crucial but opaque role in the pharmaceutical supply chain. And the findings may provide further impetus for legislative action to curb practices that critics say contribute to the ...
Santa Monica-based prescription medication discount provider GoodRx Holdings Inc. wants its customers and other medication ...
“PBMs are the only ones in the prescription drug supply chain whose focus is on bringing ... a large but ultimately limited pie; the modern PBM is just one of the wily, many-tentacled entities ...
Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...
"While this information is theoretically available to the public, institutional owners' holdings are challenging to identify ...